NDA 9585, held by Bayer Pharms. Hydrocortisone.
As of Nov 13, 2026, NDA 9585 (Cort-Dome), held by Bayer Pharms, was not approved, with 0 approved supplements and 0 published complete response letters.
| Product | Active ingredient | Marketing |
|---|---|---|
| Cort-Dome1% · cream;topical | Hydrocortisone | Discontinued |
| Cort-Dome0.5% · cream;topical | Hydrocortisone | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters